These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 25732373)

  • 41. Enhanced dissolution of oxcarbazepine microcrystals using a static mixer process.
    Douroumis D; Fahr A
    Colloids Surf B Biointerfaces; 2007 Oct; 59(2):208-14. PubMed ID: 17588726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improved compressibility, flowability, dissolution and bioavailability of pioglitazone hydrochloride by emulsion solvent diffusion with additives.
    Patil SV; Pawar AP; Sahoo SK
    Pharmazie; 2012 Mar; 67(3):215-23. PubMed ID: 22530302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Adrenaline for self treatment of anaphylactic reactions. Indications, available preparations and prescription rules].
    Rønborg SM; Olsen OT; Heinig JH; Malling HJ
    Ugeskr Laeger; 1996 Aug; 158(32):4539-43. PubMed ID: 8759396
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method.
    Jelvehgari M; Atapour F; Nokhodchi A
    Arch Pharm Res; 2009 Jul; 32(7):1019-28. PubMed ID: 19641883
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alginate-magnesium aluminum silicate films: effect of plasticizers on film properties, drug permeation and drug release from coated tablets.
    Pongjanyakul T; Puttipipatkhachorn S
    Int J Pharm; 2007 Mar; 333(1-2):34-44. PubMed ID: 17056214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Controlled poorly soluble drug release from solid self-microemulsifying formulations with high viscosity hydroxypropylmethylcellulose.
    Yi T; Wan J; Xu H; Yang X
    Eur J Pharm Sci; 2008 Aug; 34(4-5):274-80. PubMed ID: 18541418
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epinephrine in anaphylaxis: doubt no more.
    Song TT; Lieberman P
    Curr Opin Allergy Clin Immunol; 2015 Aug; 15(4):323-8. PubMed ID: 26110682
    [TBL] [Abstract][Full Text] [Related]  

  • 48. QbD-enabled systematic development of gastroretentive multiple-unit microballoons of itopride hydrochloride.
    Bansal S; Beg S; Asthana A; Garg B; Asthana GS; Kapil R; Singh B
    Drug Deliv; 2016; 23(2):437-51. PubMed ID: 24865292
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
    Maghsoodi M; Sadeghpoor F
    Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Preparation and characterization of camptothecin (CPT)-loaded folate-conjugated dextran nanoparticles for tumor-targeted drug delivery using supercritical antisolvent method.
    Zhao X; Wang D; Zu Y; Jiang R; Zhao D; Li Y; Zu B; Sun Z; Zhang Q
    J Control Release; 2011 Nov; 152 Suppl 1():e90-2. PubMed ID: 22195950
    [No Abstract]   [Full Text] [Related]  

  • 51. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers.
    Garg A; Singh S
    Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Auvi-Q epinephrine auto-injector returns.
    Med Lett Drugs Ther; 2017 Feb; 59(1515):33. PubMed ID: 28222060
    [No Abstract]   [Full Text] [Related]  

  • 53. A preliminary study of intranasal epinephrine administration as a potential route for anaphylaxis treatment.
    Srisawat C; Nakponetong K; Benjasupattananun P; Suratannon C; Wachirutmanggur L; Boonchoo S; Pankaew D; Laocharoenkiat A; Pacharn P; Jirapongsananuruk O; Visitsunthorn N; Vichyanond P
    Asian Pac J Allergy Immunol; 2016 Mar; 34(1):38-43. PubMed ID: 26994624
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risperidone solid dispersion for orally disintegrating tablet: its formulation design and non-destructive methods of evaluation.
    Rahman Z; Zidan AS; Khan MA
    Int J Pharm; 2010 Nov; 400(1-2):49-58. PubMed ID: 20801200
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Update on epinephrine for the treatment of anaphylaxis.
    Pongracic JA; Kim JS
    Curr Opin Pediatr; 2007 Feb; 19(1):94-8. PubMed ID: 17224669
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Formation of bicalutamide nanodispersion for dissolution rate enhancement.
    Li C; Li C; Le Y; Chen JF
    Int J Pharm; 2011 Feb; 404(1-2):257-63. PubMed ID: 21093558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Physicochemical characterization by AFM, FT-IR and DSC and biological assays of a promising antileishmania delivery system loaded with a natural Brazilian product.
    Marquele-Oliveira F; Torres EC; Barud Hda S; Zoccal KF; Faccioli LH; Hori JI; Berretta AA
    J Pharm Biomed Anal; 2016 May; 123():195-204. PubMed ID: 26897464
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epinephrine auto-injector pandemic.
    Campbell RL; Manivannan V; Hartz MF; Sadosty AT
    Pediatr Emerg Care; 2012 Sep; 28(9):938-42. PubMed ID: 22940899
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Non-destructive methods of characterization of risperidone solid lipid nanoparticles.
    Rahman Z; Zidan AS; Khan MA
    Eur J Pharm Biopharm; 2010 Sep; 76(1):127-37. PubMed ID: 20470882
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Ternary complexation of carvedilol, beta-cyclodextrin and citric acid for mouth-dissolving tablet formulation.
    Pokharkar V; Khanna A; Venkatpurwar V; Dhar S; Mandpe L
    Acta Pharm; 2009 Jun; 59(2):121-32. PubMed ID: 19564138
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.